Advances in Treatment of Urinary Bladder Cancer
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: closed (15 May 2024) | Viewed by 6886
Special Issue Editor
Special Issue Information
Dear Colleagues,
Urinary bladder cancer is among the top ten most common cancer types in the world, with approximately 550,000 new cases annually. At present, 75% of cases are non-muscle-invasive bladder cancer (NMIBC), and the others are muscle-invasive (MIBC), a progression from the first kind. The high prevalence of urinary bladder cancer places a significant economic burden on health systems. New advancements are required in the diagnostic setting to enhance early diagnosis and reduce the number of invasive procedures. More precise and reproducible radiological approaches have started to be utilized for both staging and the monitoring of disease progression. The identification of targets and potential biomarkers based on genomic sequencing analyses can also be useful for predicting the response of novel therapeutic strategies. Therapy has in recent years evolved from surgery to oncological combination therapies, and more recently, immunotherapeutic strategies have been added to the treatment arsenal.
This Special Issue aims to present new and innovative approaches and results relating to basic science, translational research, and epidemiology in the field of urinary bladder cancer. The scope entails studies on non-muscle-invasive urinary bladder cancer (NMIBC) as well as those on muscle invasive urinary bladder cancer (MIBC) and papers investigating molecular biomarkers’ response to treatment and radiomics to improve staging in urinary bladder cancer. We welcome original articles and review papers.
Dr. Amir M. Sherif
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urinary bladder cancer
- radiomics
- diagnosis
- biomarkers
- chemo-immunotherapy
- targeted therapy
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.